Corneal endotheliitis is an inflammatory eye condition that affects the inner cell layer of the cornea. It can cause sudden blurry vision, light sensitivity, and seeing halos, and a doctor may see corneal swelling and fine deposits. Many people with corneal endotheliitis improve with prompt treatment using anti-inflammatory eye drops and, when triggered by a virus, antiviral medication. Episodes can last days to weeks and may recur, but most people do well with care and vision often returns toward baseline. If you notice early symptoms of corneal endotheliitis like new glare or haze in one eye, talking with your healthcare provider can bring clarity and reassurance.
Overview
Corneal endotheliitisSymptoms
Early symptoms of corneal endotheliitis often appear in one eye as sudden blurry vision. People may notice redness, light sensitivity, tearing, and rainbow halos around lights. Eye pain and a dull pressure-like ache are common, sometimes worse on waking.
Outlook and prognosis
Many living with corneal endotheliitis do well when treatment starts early, especially if swelling and eye pressure are controlled. Vision often improves over days to weeks, though some episodes can recur. Regular follow‑up helps protect the cornea and catch flare-ups promptly.
Causes and risk factors
Corneal endotheliitis usually stems from viral infections—herpes simplex, varicella‑zoster, or cytomegalovirus—and less often autoimmune reactions or post‑surgical inflammation. Risk increases with eye herpes history, immunosuppression, ocular surgery or transplants, and diabetes. No consistent genetic risk; lifestyle factors affect infection control.
Genetic influences
Genetics plays a limited role in corneal endotheliitis. Most cases stem from infections or immune triggers, not inherited variants. Rarely, underlying corneal dystrophies or immune-related gene differences may influence susceptibility or recovery.
Diagnosis
Diagnosis of corneal endotheliitis relies on a slit‑lamp exam, noting corneal swelling and deposits on the back layer. An eye specialist may also check eye pressure. If infection is suspected, a fluid sample can be tested for viruses.
Treatment and drugs
Treatment for corneal endotheliitis targets the trigger and calms inflammation to clear corneal swelling and restore vision. Doctors often use antiviral or antibacterial drops or tablets when infection is suspected, plus corticosteroid eye drops and careful pressure control. Close follow‑up adjusts medicines as the cornea heals.
Symptoms
Corneal endotheliitis often causes sudden blurry or foggy vision, halos around lights, and sensitivity to light, usually in one eye. You might notice small changes at first, like needing to squint at your phone or feeling dazzled by headlights at night. Some early symptoms of Corneal endotheliitis can be worse in the morning and shift through the day as the cornea swells and clears. Symptoms can differ from one person to another and may come and go.
Things can look smeared or veiled, as if a film sits on the eye. Fine print and road signs may be harder to read. In many people with Corneal endotheliitis, vision blurs more in one eye than the other.
Bright lights may create halos, starbursts, or streaks, especially at night. Headlights and oncoming traffic can feel dazzling. What once felt effortless can start to require more energy or focus.
Bright rooms or sunlight can feel uncomfortable. Sunglasses may help, but screens and overhead lighting can still be bothersome. Some prefer dimmer settings until the eye settles.
The white of the eye can look pink or bloodshot. Others may notice the redness even before you do. Redness can be mild or moderate.
How people usually first notice Corneal endotheliitis?
People often first notice corneal endotheliitis when one eye suddenly looks hazy and vision turns blurry, sometimes with halos around lights, especially after waking. The eye may feel mildly sore or light-sensitive, and a doctor may see corneal swelling with tiny inflammatory deposits on the back surface of the cornea. These first signs of corneal endotheliitis often prompt an urgent eye exam, where testing can look for triggers like herpes viruses or recent eye surgery to guide treatment.
Types of Corneal endotheliitis
Corneal endotheliitis can look different from person to person, and what’s affected most is how clearly you see and how your eye feels day to day. Some people wake with foggy vision that clears slowly, while others notice light sensitivity and halos that make night driving hard. When people talk about types of corneal endotheliitis, they often mean the cause or pattern—like a viral trigger versus an autoimmune flare—which can shift the balance of symptoms over time. If you’re searching for types of corneal endotheliitis, most clinicians use cause-based categories that help guide treatment.
HSV-related
Vision often blurs with morning haze, mild pain, and light sensitivity. Doctors may see coin-shaped swelling on the cornea’s inner layer. Flares and remissions can happen over time.
VZV-related
Symptoms can follow shingles with eye redness, aching, and glare. Swelling can be patchy and may sit over nerves affected by the prior rash. Some may have pressure spikes inside the eye.
CMV-related
Blurring and halos are common, often with minimal redness. A ring-like or coin-shaped swelling may move slowly across the cornea. Eye pressure can rise and needs close monitoring.
Autoimmune-associated
People may notice fluctuating blur and glare during systemic flares. The eye surface can look relatively quiet even when the inner layer is inflamed. Treating the body-wide condition can help calm the eye.
Post-surgical
Symptoms start after an eye procedure with haze, light sensitivity, and discomfort. Inflammation targets the inner corneal layer where tiny pumps normally keep it clear. Early treatment can speed recovery and protect vision.
Idiopathic
Vision can be intermittently cloudy with mild light sensitivity. No clear trigger is found despite testing. Management focuses on calming inflammation and watching for recurrences.
What genetics can tell you about symptoms
Certain HLA gene variations, especially HLA-B27 and HLA-DR, raise the chance of immune flare-ups that can inflame the corneal endothelium, causing eye pain, redness, light sensitivity, and blurred or hazy vision. Variants affecting antiviral immunity may also heighten herpesvirus-triggered endotheliitis, leading to similar symptoms.
Causes and risk factors
Corneal endotheliitis is usually caused by herpes viruses like the cold sore virus, the shingles virus, or cytomegalovirus (CMV). It can also follow eye surgery, a corneal transplant, trauma, or a flare of autoimmune inflammation. Risk factors for corneal endotheliitis include prior cold sores or shingles, long-term steroid use, immune suppression, and recent eye procedures. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). There is no strong inherited risk known, but stress or illness can trigger viral reactivation and raise short-term risk.
Environmental and biological risk factors
When the inner layer of your cornea becomes inflamed, vision can turn hazy, lights may halo, and the eye can feel tender or light‑sensitive. Doctors often group risks into internal (biological) and external (environmental). Below are the main environmental and biological risk factors linked with corneal endotheliitis. Knowing the early symptoms of corneal endotheliitis is helpful, but understanding what raises risk can help you act quickly.
Past infection with herpes simplex or shingles can reactivate and inflame the cornea’s inner layer. The virus can travel along nerves and trigger endotheliitis during a flare. Reactivation is more likely when immunity is lowered by illness or medicines.
CMV can infect the corneal endothelium and cause swelling and blurred vision. Risk is higher when the immune system is suppressed. Reactivation can occur even after a remote infection.
Health conditions that reduce immune defenses, such as HIV infection or uncontrolled diabetes, increase susceptibility to endotheliitis. Lower defenses make viral reactivation and secondary inflammation more likely.
Long-term or high-dose steroid eye drops, injections, or pills can lower local immune protection. This can allow herpes-family viruses to reactivate in the eye and inflame the endothelium.
Genetic risk factors
For many, corneal endotheliitis doesn’t come from a single inherited cause, but genetics can still shape vulnerability and the intensity of inflammation. Scientists are still mapping genetic risk factors for corneal endotheliitis, and most clues point to how the immune system handles herpesviruses that can involve the cornea. Some risk factors are inherited through our genes. So far, no single high-impact gene has been confirmed.
No single-gene cause: Most people with corneal endotheliitis do not have a single inherited mutation that directly causes it. Current research has not identified a consistent, high-impact gene for this condition.
Immune response genes: Differences in genes that guide antiviral defenses may influence who develops corneal endotheliitis and how severe it becomes. These variations can alter how efficiently the immune system recognizes and clears herpesviruses in the eye.
Primary immunodeficiency: Rare, inherited immune conditions can raise the risk of persistent or recurrent viral eye infections that involve the corneal endothelium. People with these conditions are more likely to have severe or difficult-to-treat episodes.
Family susceptibility: A family pattern of frequent or severe herpesvirus infections can signal shared inherited traits in immune defense. This background may raise the chance of corneal endotheliitis during a viral flare.
Lifestyle risk factors
Several daily habits can influence the chance of triggering corneal endothelial inflammation, the intensity of a flare, and how well the cornea recovers. While infections often underlie this condition, behavior-driven immune stress and ocular hygiene play a role in reactivation risk and healing. The following highlights lifestyle risk factors for corneal endotheliitis and practical ways habits may affect symptoms and outcomes.
Sleep loss and psychological stress can weaken antiviral immune responses and raise the chance of herpes-family viral reactivation that can inflame the corneal endothelium. Stress management and consistent sleep may reduce flare frequency and shorten recovery.
Overnight wear, stretched replacement schedules, or poor lens hygiene can increase ocular infection risk and corneal inflammation that may precipitate endothelial involvement. Strict wear-time limits and clean handling lower that risk.
Frequent or forceful rubbing causes microtrauma that can worsen corneal edema and inflammation during an episode. Using lubricants and treating itch can help break the rub cycle and protect the endothelium.
Using steroid eye drops without medical guidance can promote viral reactivation and intensify endothelial inflammation. Always use topical steroids only as prescribed and paired with appropriate antiviral therapy when indicated.
Risk prevention
You can lower your risk of corneal endotheliitis by reducing triggers for viral eye flare-ups, protecting your eyes, and staying on top of post-procedure care. Prevention works best when combined with regular check-ups. If you’ve had herpes eye disease or shingles before, targeted steps like vaccines and antiviral medicine can make recurrences less likely. Learning the early symptoms of corneal endotheliitis and acting fast can help protect vision.
Getting a shingles vaccine can reduce reactivation of the virus that may inflame the cornea. This is especially helpful for adults over 50 or anyone with a history of shingles in or around the eye.
If you’ve had herpes eye disease, your doctor may recommend daily antiviral medicine to prevent flares. This can lower the chance of inflammation reaching the corneal lining.
Wash and dry hands before handling lenses, and clean, store, and replace them exactly as directed. Avoid sleeping in lenses unless your eye doctor has approved it.
Do not swim, shower, or use hot tubs while wearing contact lenses. Water exposure raises the risk of germs that can set off corneal inflammation.
Transmission
Corneal endotheliitis is an inflammation inside the clear front window of the eye and, by itself, is not contagious. There is no direct transmission of corneal endotheliitis from one eye or person to another; instead, the underlying viruses—most often herpes simplex, varicella‑zoster (shingles/chickenpox), or cytomegalovirus (CMV)—are what spread. Herpes simplex usually spreads through close contact with saliva or skin lesions such as a cold sore; varicella‑zoster through contact with shingles or chickenpox blisters or, less often, respiratory droplets; and CMV through contact with body fluids. The risk to others from someone with corneal endotheliitis is generally low, but careful handwashing and not sharing towels, eye drops, or cosmetics reduce the chance of passing along these viruses. Within the same person, these viruses can occasionally transfer from a cold sore or shingles rash to the eye by touch, so avoid rubbing the eyes until lesions have healed.
When to test your genes
Consider genetic testing if you’ve had recurrent or unexplained corneal swelling/inflammation, early-onset disease, or a strong family history of corneal disorders (like FECD) or early corneal transplants. Test before corneal surgery or when inflammation is hard to control to guide treatment and follow-up. Seek counseling if relatives are affected.
Diagnosis
When corneal endotheliitis flares, vision may look foggy, lights can halo, and mornings often start with more blur that eases a bit as the day goes on. Doctors usually begin with a detailed eye exam and questions about how symptoms started and changed over time. The diagnosis of Corneal endotheliitis is based on what the eye specialist sees at the microscope, supported by targeted tests that confirm the cause and rule out similar conditions. Pinpointing the trigger—often viral or immune—guides the right treatment plan.
Clinicians ask about sudden versus gradual blur, light sensitivity, eye pain, and whether symptoms are worse in the morning. Triggers like recent illness, stress, or prior eye surgery can offer clues.
The cornea is examined for localized swelling, fine deposits on the back surface, and a pattern that fits endotheliitis. Findings such as sectoral edema or coin-shaped lesions help distinguish it from other causes.
Pressure inside the eye is measured because endotheliitis can block fluid outflow and raise pressure. Elevated readings support the diagnosis and help guide urgent management to protect the optic nerve.
Corneal thickness is measured to confirm and track swelling. Changes over time help assess response and differentiate chronic conditions like dystrophies from active inflammation.
Stages of Corneal endotheliitis
Corneal endotheliitis does not have defined progression stages. It tends to occur in flares that can improve with treatment, and the pattern varies by the underlying cause, so it doesn’t follow a steady, stepwise decline. Diagnosis is based on symptoms—blurred vision, halos, light sensitivity, and sometimes mild eye pain—with an eye exam that looks for corneal swelling and deposits, and checks eye pressure; early symptoms of corneal endotheliitis can be easy to miss. Different tests may be suggested to help confirm the cause, such as imaging at the slit lamp, corneal thickness measurements, or targeted viral testing when needed.
Outlook and prognosis
For many living with corneal endotheliitis, the course depends on how quickly treatment starts and whether episodes recur. Early care can make a real difference, especially for vision that’s gone hazy from corneal swelling. Some people have a single episode that settles with anti-inflammatory or antiviral drops, while others face repeat flares that need longer treatment or steroid-sparing options. Doctors call this the prognosis—a medical word for likely outcomes.
When thinking about the future, it helps to know that most people recover useful vision after an acute flare if the cornea clears. The main long-term risk is damage to the corneal endothelial cells; if too many are lost over time, lasting swelling can blur vision and, in advanced cases, lead to the need for a corneal transplant. The outlook is not the same for everyone, but viral-triggered cases that are treated promptly tend to have better recovery than those with frequent, untreated relapses. Asking your eye doctor about early symptoms of corneal endotheliitis—like sudden morning blur, light sensitivity, or a ring of small deposits—can help you act quickly if it returns.
In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, but with corneal endotheliitis the biggest drivers are the cause (often viral), response to therapy, and number of recurrences. Mortality is not increased by corneal endotheliitis itself; the concern is vision loss, which is usually preventable with timely care. With ongoing care, many people maintain stable vision and go months to years between flares, adjusting treatment at the first sign of trouble. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Blurred or fluctuating vision can come and go, making reading or night driving harder on some days than others. Episodes may leave the cornea swollen and sensitive to light, and repeated inflammation can slowly reduce the health of the inner corneal layer. Long-term effects vary widely, but some people develop scarring or higher eye pressure over the years. Recognizing early symptoms of corneal endotheliitis can help people understand why their vision shifts during flares.
Blurry or foggy vision may wax and wane, sometimes worse in the morning. For many, this makes tasks like screen work or night driving less reliable day to day.
Fluid can build up in the cornea, causing halos, glare, and discomfort. Swelling episodes in corneal endotheliitis may last days to weeks and can recur.
Repeated inflammation can reduce the number of inner corneal cells over time. Lower cell counts raise the risk of chronic corneal edema and vision decline.
Some people experience repeat flares separated by quiet periods. With each flare, symptoms of corneal endotheliitis can return, sometimes affecting the same eye.
How is it to live with Corneal endotheliitis?
Living with corneal endotheliitis often means days when vision looks foggy or halos flare around lights, especially in the morning, then slowly clears as the day goes on. Flares can be unpredictable and may bring light sensitivity, eye discomfort, and anxiety about whether vision will recover, so many plan around follow-up visits, drops, and rest for the eyes. Work that demands prolonged screen time or driving at night can be harder during active episodes, and loved ones may need to help with rides, errands, or simply understanding that plans might change during a flare. With prompt treatment and careful follow-up, many regain clear vision between episodes, but staying prepared and communicating needs makes daily life smoother for everyone involved.
Treatment and drugs
Treatment for corneal endotheliitis focuses on calming inflammation, protecting the cornea, and treating any underlying trigger such as a viral infection. Doctors typically start steroid eye drops to reduce swelling and clouding, often alongside antiviral medication by mouth (such as acyclovir or valacyclovir) if a herpes virus is suspected; a doctor may adjust your dose to balance benefits and side effects. If eye pressure rises—a common feature with corneal endotheliitis—pressure-lowering drops are added, and in resistant cases, a short course of oral steroids or stronger antivirals may be used. Supportive care can make a real difference in how you feel day to day, including frequent lubrication and close follow-up to monitor clarity, pressure, and vision. Severe or recurrent corneal endotheliitis that leaves lasting corneal haze may eventually require a partial-thickness corneal transplant (endothelial keratoplasty), but many people improve with medicines alone.
Non-drug treatment
Flare-ups can make vision look foggy and lights too bright, disrupting reading, driving, or screen time. Non-drug treatments often lay the foundation for comfort and recovery, while medicines address the underlying inflammation or infection. If you notice early symptoms of corneal endotheliitis—like sudden blur, halos around lights, or eye ache—contact an eye doctor promptly. The options below focus on protecting the eye, easing strain, and supporting healing between appointments.
Place a clean, cool compress over closed eyelids for 5–10 minutes to ease discomfort and light sensitivity. This can reduce surface irritation without putting pressure on the eye. Avoid ice directly on the skin.
Wear UV-blocking sunglasses and a brimmed hat outdoors to cut glare and prevent squinting. Reducing light triggers can make daily activities safer when corneal endotheliitis is active.
Stop wearing contact lenses until your eye specialist clears you. Lenses can trap debris and worsen irritation during corneal endotheliitis.
Use preservative-free artificial tears to relieve dryness and wash away irritants. Single-use vials lower the risk of added irritation when the eye is inflamed.
Your genes may have an impact on how drugs work for you
Some people process antiviral, anti-inflammatory, and pressure-lowering eye drops differently because of gene variants that change drug activation, breakdown, or targets. Pharmacogenetic testing isn’t routine for corneal endotheliitis, but genetics may explain varied responses and side‑effect risks.
Pharmacological treatments
Treatment focuses on calming the corneal inflammation, clearing any virus that may be driving it, and protecting vision while the cornea heals. Early symptoms of corneal endotheliitis like sudden blurred vision and light sensitivity can ease within days once the right medicines start working, though full clarity may take longer. Not everyone responds to the same medication in the same way. Your eye specialist will tailor choices to the suspected cause (such as herpes viruses or CMV), how severe the swelling is, and whether eye pressure has risen.
Prednisolone acetate 1% or dexamethasone drops reduce swelling and light sensitivity. They are often started frequently, then tapered as the cornea clears. Dosing may be increased or lowered gradually to find the lowest dose that keeps inflammation quiet.
Acyclovir, valacyclovir, or famciclovir help control herpes viruses that commonly trigger endotheliitis. These are usually paired with steroid drops to prevent flare-ups. If one option isn’t effective, second-line or alternative drugs may be offered.
Valganciclovir tablets and/or topical ganciclovir gel target cytomegalovirus when CMV endotheliitis is suspected or confirmed. Blood tests may be needed during tablet therapy to check for rare side effects. Your specialist will balance benefits and risks based on your overall health.
Sodium chloride 5% drops or ointment can pull excess fluid out of the cornea. This may reduce hazy vision while the main treatments take effect. It is a comfort measure and does not treat the underlying cause.
Genetic influences
There’s no single gene known to directly cause corneal endotheliitis. Genetics is only one piece of the puzzle, but differences in immune-system genes may influence how strongly someone reacts to common triggers like herpes viruses, which can spark inflammation in the cornea’s inner layer. This may shape who is more likely to develop inflammation, how often it flares, or how severe the swelling and vision changes become. Still, corneal endotheliitis does not typically run in families, and having a relative with it usually doesn’t raise your personal risk much. If several relatives have corneal endothelial problems, clinicians will also consider inherited conditions that can look similar, such as Fuchs endothelial dystrophy or other corneal dystrophies, which are distinct from corneal endotheliitis. Because of this, genetic testing isn’t routinely used for corneal endotheliitis, though it may be helpful when early symptoms of corneal endotheliitis are unusual, long-lasting, or overlap with a suspected corneal dystrophy.
Is Corneal endotheliitis genetic?
Genetics plays a limited role in corneal endotheliitis. Most cases stem from infections or immune triggers, not inherited variants. Rarely, underlying corneal dystrophies or immune-related gene differences may influence susceptibility or recovery.
Pharmacogenetics—how genetics influence drug effects
Treatment for corneal endotheliitis often relies on antiviral medicines to target herpes-family viruses and steroid eye drops to calm inflammation, but people do not all respond the same way. Inherited differences can affect how sensitive someone is to steroid drops, especially the risk of a steroid‑related rise in eye pressure that needs close monitoring and, sometimes, pressure‑lowering drops. If a beta‑blocker eye drop like timolol is used to control that pressure, some people naturally break it down more slowly, which can increase the chance of side effects such as a slow pulse or tiredness; your eye doctor may choose a different drop or watch more closely in that situation. For antiviral drugs commonly used in corneal endotheliitis (such as acyclovir/valacyclovir or ganciclovir/valganciclovir), dosing is guided mostly by kidney function and blood counts; genes are not routinely used to set doses, although research continues into drug transport and clearance. Pharmacogenetic testing for corneal endotheliitis is not a standard part of care today, and most treatment decisions are based on the virus involved, your overall health, and how your eye responds. Genetics is only one factor in how medicines work for you, and your care team will match treatment to your situation over time.
Interactions with other conditions
Corneal endotheliitis often shows up alongside viral eye problems, especially herpes viruses (cold sores or shingles) and cytomegalovirus, so flare-ups can track with viral reactivation or times when the immune system is run down. In people living with uveitis or on immune-suppressing medicines for autoimmune disease, the added inflammation or lowered defenses can make Corneal endotheliitis more likely and harder to quiet. After a corneal transplant, Corneal endotheliitis—especially from CMV—can mimic graft rejection, so teams watch closely because the treatments differ. Existing glaucoma can complicate things too, since inflammation and steroid drops used for swelling may raise eye pressure, and that pressure rise can further threaten vision. Diabetes and other conditions that slow healing can stretch out recovery, and early symptoms of Corneal endotheliitis such as light sensitivity, blurred vision, and mild eye pain may be mistaken for “just a viral pink eye,” delaying care. Ask if any medications for one condition might interfere with treatment for another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden cloudy vision after an eye infection, a fever, or even without a clear trigger. Someone might wake to a hazy film over one eye, mild aching, and strong glare from headlights. Looking back, these stories match what we now recognize as corneal endotheliitis—an inflammatory problem affecting the thin cell layer on the inner surface of the cornea that keeps it clear.
First described in the medical literature as a distinct pattern of corneal swelling with tiny deposits on the back of the cornea, early reports focused on what doctors could see with a slit lamp. Before modern imaging, clinicians noticed that the cornea would swell in patches, sometimes forming a map-like pattern, while eye pressure might rise for a time. These observations helped separate endotheliitis from more general corneal inflammation.
From early theories to modern research, the story of corneal endotheliitis has traced a path from symptom-based descriptions to cause-based understanding. In the late 20th century, links to certain viruses—especially herpes family viruses—became clearer as lab testing and antiviral treatments improved. Researchers realized that in many people, a quiet, previously encountered virus could reactivate and trigger focused inflammation in the corneal endothelial cells. This shift explained why episodes could recur and why antiviral medicines often helped.
As medical science evolved, clinicians also recognized that corneal endotheliitis can look different from person to person. Some episodes are mild, with brief blur and light sensitivity. Others are more dramatic, with marked corneal swelling and pressure spikes that need prompt care. Reports from different regions noted similar patterns, suggesting shared causes rather than purely environmental triggers. Over time, descriptions became more precise, distinguishing endotheliitis from conditions like uveitis, keratitis, and primary endothelial diseases.
Advances in eye imaging—such as specular and confocal microscopy—allowed doctors to visualize and count endothelial cells, showing how inflammation can temporarily knock these cells off balance. At the same time, gentler sampling techniques and better PCR testing of eye fluids strengthened the connection to viral triggers in select cases, while still acknowledging that not every episode has a confirmed cause.
In recent decades, awareness has grown that timely treatment matters. Historical case series documented how early antiviral and anti-inflammatory therapy could shorten attacks and preserve the limited population of endothelial cells we rely on for lifelong corneal clarity. This practical lesson—treat early, monitor closely, protect the endothelium—has guided modern care.
Looking back helps explain why today’s approach to corneal endotheliitis blends careful examination, consideration of infectious triggers, and tailored treatment. Each chapter—from bedside observation to lab confirmation—has clarified a condition that once sat in a gray zone, bringing it into sharper clinical focus.